This is a preview of subscription content, log in via an institution to check access.
References
Bickers DR (1983) Drug, carcinogen and steroid hormone metabolism in the skin. In: Goldsmith LA (ed) Biochemistry and physiology of the skin. Oxford University Press, New York Oxford, pp 1169–1186
Bösterling B, Trudell JR (1983) Leukotriene B4 metabolism by hepatic cytochrome P-450. Biochem Biophys Res Commun 114:850–854
Bösterling B, Trudell JR (1983) Evidence for leukotriene A4 as an intermediate in the conversion of 5-HPETE to leukotriene B4 catalyzed by cytochrome P-450. Biochem Biophys Res Commun 115:995–1001
Capdevila G, Parkhill L, Chacos N, Okita R, Masters BSS, Estabrook RW (1981) The oxidative metabolism of arachidonic acid by purified cytochrome P-450. Biochem Biophys Res Commun 101:1357–1363
Capdevila J, Marnett LJ, Chacos N, Prough RA, Estabrook RW (1982) Cytochrome P-450 dependent oxygenation of arachidonic acid by hydroxyeicosatetraenoic acids. Proc Natl Acad Sci USA 79:767–770
Czarnetzki BM (1983) Release of eosinophil chemotactic leukotrine from, neutrophils of patients with pseudo-allergic reactions. Int Arch Allergy Appl Immunol 70:80–82
Czarnetzki BM, Grabbe J (1983) Biological and chemical characterization of eosinophil chemotactic factors from human leukocytes. Agents Actions [Suppl] 12:204–216
Czarnetzki BM, König W, Lichtenstein LM (1976) Eosinophil chemotactic factor (ECF). 1. Relaase from polymorphonuclear leukocytes by the calcium ionophore A23187. J Immunol 117: 229–234
Czarnetzki BM, Frosch PJ, Mardin M, Macher E (1983) Leukotriene B4 and neutrophil-derived eosinophil chemotactic factor: comparison of their biological activities. Monogr Allergy 18:193–195
Ford-Hutchinson AW, Rackham A, Zambom R, Rokach J, Roy S (1983) Comparative biological activities of synthetic leukotriene B4 and its w-oxidation products. Prostaglandins 25:29–37
Grabbe J, Czarnetzki BM, Mardin M (1982) Chemotactic leukotrienes in psoriasis. Lancet II:1464
Grabbe J, Czarnetzki BM, Mardin M (1984) Release of lipoxygenase products of arachidonic acid from freshly isolated human keratinocytes. Arch Dermatol Res 276:128–130
Grabbe J, Czarnetzki BM, Resenbach, I, Mardin M (1984) Identification of chemotactic lipoxygenase products of arachidonate metabolism in psoriatic skin. J Invest Dermatol (in press)
Netter KJ (1981) Inhibition of oxidative drug metabolism in microsomes. Pharmacol Ther 10:515–535
Oliw EH, Guengerich FP, Oates JA (1982) Oxygenation of arachidonic acid by hepatic monooxygenases. J Biol Chem 257:3771–3781
Ullrich V, Weber P (1972) The O-dealkylation of 7-ethoxycoumarin by liver microsomes. Hoppe-Seyler's Z Physiol Chem 353:1171–1177
Ullrich V, Frommer V, Weber P (1973) Differences in the O-dealcylation of 7-ethoxycoumarin after pretreatment with phenobarbital and 3-methylcholanthrene. Hoppe-Seyler's Z Physiol Chem 354:510–520
Vorhees JJ (1983) Leukotrienes and other lipoxygenase products in the pathogenesis and therapy of psoriasis and other dermatoses. Arch Dermatol 119:541–547
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Czarnetzki, B.M., Goerz, G., Bolsen, K. et al. Cytochrome P-450-dependent production of chemotactic arachidonate metabolites from human neutrophils. Arch Dermatol Res 276, 243–245 (1984). https://doi.org/10.1007/BF00414236
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00414236